MP
AGN

Manikay Partners’s Allergan plc AGN Stock Holding History

Manikay Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-30,827
Closed -$5.16M – 32
2019
Q2 		$5.16M Buy
+30,827
New +$4.27M 0.43% 27
2016
Q4 		– Sell
-302,500
Closed -$69.7M – 47
2016
Q3 		$69.7M Sell
302,500
-62,750
-17% -$15.3M 3.26% 14
2016
Q2 		$84.4M Sell
365,250
-49,750
-12% -$11.5M 6.43% 5
2016
Q1 		$111M Buy
415,000
+250,000
+152% +$71.6M 6.35% 5
2015
Q4 		$51.6M Buy
+165,000
New +$49.1M 2.65% 16
2015
Q2 		– Sell
-256,527
Closed -$76.3M – 39
2015
Q1 		$76.3M Buy
+256,527
New +$73.1M 4.71% 7

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Manikay Partners's AGN Position: Q3 2019 in Review

Manikay Partners sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 30,827 shares — an estimated $5.16M sold.

Manikay Partners first reported a position in AGN in Q1 2015 and held it in 6 quarters. The position peaked at $111M in Q1 2016. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Manikay Partners reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Manikay Partners sold 30,827 Allergan plc shares in Q3 2019, an estimated $5.16M.
  • Manikay Partners first reported a position in Allergan plc in Q1 2015 and held it in 6 quarters.
  • Manikay Partners's Allergan plc position peaked at $111M in Q1 2016.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Manikay Partners's 13F filing for Q3 2019, filed 14 Nov 2019.